These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37680312)

  • 1. Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19.
    Zhang Z; Dai W; Zhu W; Rodriguez M; Lund H; Xia Y; Chen Y; Rau M; Schneider EA; Graham MB; Jobe S; Wang D; Cui W; Wen R; Whiteheart SW; Wood JP; Silverstein R; Berger JS; Kreuziger LB; Barrett TJ; Zheng Z
    Res Pract Thromb Haemost; 2023 Aug; 7(6):102164. PubMed ID: 37680312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
    Akanji AO; Abdullah A; Tahzeeb S
    Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
    Glueck CJ; Glueck HI; Tracy T; Speirs J; Stroop D
    Metabolism; 1993 Nov; 42(11):1410-9. PubMed ID: 8231835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.
    Zuo Y; Warnock M; Harbaugh A; Yalavarthi S; Gockman K; Zuo M; Madison JA; Knight JS; Kanthi Y; Lawrence DA
    medRxiv; 2020 Dec; ():. PubMed ID: 32909005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.
    Thøgersen AM; Söderberg S; Jansson JH; Dahlén G; Boman K; Nilsson TK; Lindahl B; Weinehall L; Stenlund H; Lundberg V; Johnson O; Ahrén B; Hallmans G
    Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):33-40. PubMed ID: 15167204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo.
    Biemond BJ; Friederich PW; Koschinsky ML; Levi M; Sangrar W; Xia J; Büller HR; ten Cate JW
    Circulation; 1997 Sep; 96(5):1612-5. PubMed ID: 9315555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
    Lu H; Bruckert J; Soria J; Li H; de Gennes JL; Legrand A; Peynet J; Soria C
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):513-6. PubMed ID: 1966796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis.
    Boffa MB
    Atherosclerosis; 2022 May; 349():72-81. PubMed ID: 35606079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoprotein(a): a link between thrombogenesis and atherogenesis].
    Vucković B; Derić M
    Med Pregl; 2007; 60(1-2):37-41. PubMed ID: 17853709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and post-surgical modification of VEGF, tPA and PAI-1 in patients with glioma.
    Salmaggi A; Croci D; Prina P; Cajola L; Pollo B; Marras CE; Ciusani E; Silvani A; Boiardi A; Sciacca FL
    Cancer Biol Ther; 2006 Feb; 5(2):204-9. PubMed ID: 16357523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
    Zitoun D; Bara L; Basdevant A; Samama MM
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype.
    Artemeva NV; Safarova MS; Ezhov MV; Afanasieva OI; Dmitrieva OA; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():53-8. PubMed ID: 25936305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].
    Armstrong VW
    Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein Lp(a) and atherothrombotic disease.
    de la Peña-Díaz A; Izaguirre-Avila R; Anglés-Cano E
    Arch Med Res; 2000; 31(4):353-9. PubMed ID: 11068075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.
    Rouy D; Grailhe P; Nigon F; Chapman J; Anglés-Cano E
    Arterioscler Thromb; 1991; 11(3):629-38. PubMed ID: 1827591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside.
    Marcovina SM; Koschinsky ML
    Curr Opin Lipidol; 2003 Aug; 14(4):361-6. PubMed ID: 12865733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) Does Not Predict Thrombotic Events and In-Hospital Outcomes in Patients with COVID-19.
    Bianconi V; Mannarino MR; Ramondino F; Fusaro J; Giglioni F; Braca M; Ricciutelli F; Lombardini R; Paltriccia R; Greco A; Lega IC; Pirro M
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis.
    Etingin OR; Hajjar DP; Hajjar KA; Harpel PC; Nachman RL
    J Biol Chem; 1991 Feb; 266(4):2459-65. PubMed ID: 1824942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.